KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Net LoansChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Healthpeak Properties (DOC) over the last 17 years, with Q4 2025 value amounting to $216.6 million.

  • Healthpeak Properties' Capital Expenditures rose 931.15% to $216.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $763.7 million, marking a year-over-year increase of 2780.98%. This contributed to the annual value of $763.7 million for FY2025, which is 2780.98% up from last year.
  • As of Q4 2025, Healthpeak Properties' Capital Expenditures stood at $216.6 million, which was up 931.15% from $222.7 million recorded in Q3 2025.
  • In the past 5 years, Healthpeak Properties' Capital Expenditures ranged from a high of $250.4 million in Q3 2022 and a low of $107.0 million during Q1 2024
  • In the last 5 years, Healthpeak Properties' Capital Expenditures had a median value of $179.2 million in 2021 and averaged $178.2 million.
  • As far as peak fluctuations go, Healthpeak Properties' Capital Expenditures surged by 6841.36% in 2022, and later plummeted by 4775.22% in 2024.
  • Healthpeak Properties' Capital Expenditures (Quarter) stood at $180.0 million in 2021, then skyrocketed by 35.98% to $244.8 million in 2022, then plummeted by 39.26% to $148.7 million in 2023, then surged by 33.22% to $198.1 million in 2024, then increased by 9.31% to $216.6 million in 2025.
  • Its last three reported values are $216.6 million in Q4 2025, $222.7 million for Q3 2025, and $158.3 million during Q2 2025.